ArcticZymes Technologies ASALTS:0DRV 76 Quick Ratio is 15.05 as of Mar. 2026, which is 40% above its 10-year median of 10.73. GuruFocus rates LTS:0DRV with a GF Score™ of 76/100 and a GF Value™ of kr23.84 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 1,412 Biotechnology companies, ArcticZymes Technologies ASA ranks better than 87.18% on this metric.
ArcticZymes Technologies ASA has a quick ratio of 15.05. It generally indicates good short-term financial strength.
The historical rank and industry rank for ArcticZymes Technologies ASA's Quick Ratio or its related term are showing as below:
LTS:0DRV'
s Quick Ratio Range Over the Past 10 Years
Min: 2.25 Med: 10.73 Max: 17.25
Current: 15.05
During the past 13 years, ArcticZymes Technologies ASA's highest Quick Ratio was 17.25. The lowest was 2.25. And the median was 10.73.
LTS:0DRV's Quick Ratio is ranked better than 87.18% of 1412
companies
in the Biotechnology industry
Industry Median: 3.6
vs LTS:0DRV: 15.05
ArcticZymes Technologies ASA (LTS:0DRV) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
ArcticZymes Technologies ASA Quick Ratio Related Terms
ArcticZymes Technologies ASA Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0DRV vs VRTX, REGN, ALNY: Quick Ratio Comparison
For the Biotechnology subindustry, ArcticZymes Technologies ASA's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ArcticZymes Technologies ASA Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ArcticZymes Technologies ASA's Quick Ratio distribution charts can be found below:
* The bar in red indicates where ArcticZymes Technologies ASA's Quick Ratio falls into.
ArcticZymes Technologies ASA Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ArcticZymes Technologies ASA (LTS:0DRV) has a Quick Ratio of 15.05 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on ArcticZymes Technologies ASA and its competitors. This is 40% above median its historical median of 10.73. Over the past decade, ArcticZymes Technologies ASA's Quick Ratio has ranged from 2.25 to 17.25. According to the industry distribution chart, ArcticZymes Technologies ASA ranks #181 out of 1412 companies in the Biotechnology industry, placing it in the top 12.8%.
Is ArcticZymes Technologies ASA's Quick Ratio too high?
ArcticZymes Technologies ASA's current Quick Ratio of 15.05 is 40% above median its 10-year median of 10.73. Over the past 10 years, this metric has ranged from a low of 2.25 to a high of 17.25. The Biotechnology industry median Quick Ratio is 3.60. ArcticZymes Technologies ASA's value of 15.05 is 318.1% above this industry median. Based on the distribution chart, ArcticZymes Technologies ASA ranks #181 out of 1412 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, ArcticZymes Technologies ASA has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ArcticZymes Technologies ASA's Quick Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ArcticZymes Technologies ASA ranks #181 out of 1412 companies for Quick Ratio. This places ArcticZymes Technologies ASA in the top 13% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 3.60. ArcticZymes Technologies ASA's value of 15.05 is 318.1% above this benchmark. Historically, ArcticZymes Technologies ASA's own Quick Ratio has ranged from 2.25 to 17.25 over the past decade. While the company's 10-year median is 10.73 vs. the industry median of 3.60, ArcticZymes Technologies ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,412 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ArcticZymes Technologies ASA's current Quick Ratio of 15.05 is 318.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on ArcticZymes Technologies ASA and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ArcticZymes Technologies ASA's current Quick Ratio is 15.05, which is 40% above median its own 10-year median of 10.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ArcticZymes Technologies ASA stock overvalued right now?
Based on GuruFocus' analysis, ArcticZymes Technologies ASA (LTS:0DRV) is currently considered Modestly Undervalued. The stock's GF Value™ is kr23.84, compared to a current price of kr20.90 — trading 12.3% below its estimated fair value. The current Quick Ratio is 15.05, which is 40% above median its 10-year median of 10.73 and 318.1% above the Biotechnology industry median of 3.60. ArcticZymes Technologies ASA's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For ArcticZymes Technologies ASA (LTS:0DRV), the current Quick Ratio is 15.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ArcticZymes Technologies ASA (LTS:0DRV) Overvalued in 2026?
Based on GuruFocus' analysis, ArcticZymes Technologies ASA stock appears to be undervalued.
The current stock price of kr20.90 is trading 12.3% below its estimated GF Value™ of kr23.84.
GuruFocus considers ArcticZymes Technologies ASA to be Modestly Undervalued.
Key valuation signals for LTS:0DRV:
Quick Ratio: 15.05 (40% above median its 10-year median of 10.73)
GF Value™: kr23.84 vs. price of kr20.90 (12.3% below fair value)
Industry Position: 318.1% above the Biotechnology median (#181 of 1412)
No single metric tells the full story. See the LTS:0DRV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Norway, Germany, France, Italy, UK, Other countries in Europe, and Rest of world.
76GF Score
Get the complete analysis for LTS:0DRV
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0DRV has been successfully added to your 
